EN | UA
EN | UA

Help Support

Back

News

# Trending Topics

  • Trial compares 1% Terbinafine vs 1% Clotrimazole C...

    A randomized controlled trial showed that for Tinea pedis (athletic foot) management, 1 week Terbinafine twice a day is as effective as 4 weeks C...

    More details
  • Paracetamol vs Ibuprofen. Which is better for trea...

    In a systematic review and meta-analysis, both Paracetamol and Ibuprofen demonstrated superior effectiveness compared to a placebo in addressing...

    More details
  • Study reveals the effect of Isotretinoin on menstr...

    Novel findings from a recent prospective observational study shed light on the impact of oral intake of Isotretinoin on menstrual cycles among ac...

    More details
  • Tirzepatide injection gets FDA approval for chroni...

    According to the notification published on 8 Nov 2023, the United States Food and Drug Administration (US-FDA) has authorized Tirzepatide injecti...

    More details
  • Study assesses efficacy of ketorolac for treatment...

    In people presenting with migraine headache, ketorolac might have similar effectiveness when compared to phenothiazines and metoclopramide for mi...

    More details
  • Is alcohol safe for rheumatoid arthritis patients...

    Rheumatoid Arthritis (RA) patients taking Methotrexate (MTX) are often advised to decrease their alcohol intake due to the increased risk of hepa...

    More details
  • Does exercise induce GERD or relieve acid reflux?...

    Different factors are accountable for the impact of exercise or physical activity on the onset of gastroesophageal reflux disease (GERD), a sessi...

    More details
  • GERD Symptoms: Could Intermittent Fasting Help?

    A study published in the "Journal of Clinical Gastroenterology" showed symptomatic relief in gastroesophageal reflux disease (GERD) sym...

    More details
  • Understanding bleeding patterns associated with ea...

    A recent study published in the Maternal-Fetal Medicine Journal found that terminated bleeding after 2 weeks is a predictive indicator for effe...

    More details
  • Leaning right is most effective position while swa...

    According to new research, a person's posture can affect how quickly a pill enters the intestines by as much as 83%. The best posture was to...

    More details

News

Medical News
See All
38
Medical News

Predicting post-stroke cognitive impairment: A new nomogram appro...

A novel dual-strategy combining a predictive risk nomogram with Montessori-based sensory education offers a promising framework for identifying a...

46
Medical News

Post-IVF pain flares common in endometriosis, large study warns!

Nearly half of women suffering from endometriosis report pelvic pain deterioration after IVF, with immediate post-cycle pain flare emerging as th...

44
Medical News

Nitazoxanide-based regimens outperform standard triple therapy in...

Compared to standard triple therapy, nitazoxanide-based therapy effectively improves H. pylori elimination rates.

57
Medical News

Liver fibrosis scores signal higher cardiovascular risk in MINOCA

Higher liver fibrosis scores signal significantly increased MACE and poorer survival in MINOCA, particularly in metabolically compromised patient...

62
Medical News

Intermittent fasting shows superior fat loss and metabolic benefi...

In early T2DM, 5:2 intermittent fasting meal replacement outperforms standard therapies in reducing BMI, abdominal fat, and body fat.

53
Medical News

Imrecoxib vs. celecoxib: New evidence supports non-inferior effic...

Imrecoxib matches celecoxib in efficacy and safety, with fewer adverse events in osteoarthritis and potential anti-inflammatory benefits in axSpA...

Regulatory News
See All
1896
Regulatory News

Etripamil nasal spray receives FDA approval for rapid relief of P...

FDA has approved intranasal etripamil for paroxysmal supraventricular tachycardia, delivering fast, on-demand restoration of normal heart rhythm....

5928
Regulatory News

FDA clears new oral therapy rilzabrutinib for treatment-resistant...

FDA approves rilzabrutinib tablets as a new oral treatment option for adults with persistent or chronic ITP who show insufficient response to sta...

4372
Regulatory News

FDA expands access to omalizumab therapy with first interchangeab...

The FDA has authorized omalizumab-igec as the first interchangeable biosimilar to omalizumab for treating asthma, urticaria, chronic rhinosinusit...

4287
Regulatory News

FDA introduces front-of-package nutrition labels to tackle chroni...

The FDA has proposed requisition of front-of-package nutrition labels on most packaged foods to clearly display levels of saturated fat, sodium,...

10571
Regulatory News

EMA issues flu vaccine composition guidance for 2025/2026 season

EMA recommends updated trivalent influenza vaccines for the 2025/2026 season, selecting strains based on global surveillance data and excluding B...

5339
Новости Здравоохранения

Reddy’s and Henlius collaborate to commercialize daratumumab bios...

Dr. Reddy’s has secured exclusive U.S. and Europe commercialization rights for Henlius’s daratumumab biosimilar HLX15 in a deal worth...

Try: